Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization

American Journal of Hematology

Volumn 85, Issue 8, 2010, Pages 611-613

  Brandow, Amanda M ^a   Jirovec, Danielle L ^a   Panepinto, Julie A ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE CHEST SYNDROME; ARTICLE; CHILD; CLINICAL PRACTICE; CONTRACEPTION; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PAIN; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; DRUG MONITORING; HEALTH PERSONNEL ATTITUDE; HEMATOLOGY; INFORMATION PROCESSING; LETTER; ONCOLOGY; PEDIATRICS; PHYSICIAN; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; STATISTICS; UTILIZATION REVIEW;

ANEMIA, SICKLE CELL; ATTITUDE OF HEALTH PERSONNEL; CHILD; CONTRACEPTION; DATA COLLECTION; DRUG MONITORING; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEMATOLOGY; HOSPITALIZATION; HUMANS; HYDROXYUREA; MALE; MEDICAL ONCOLOGY; PAIN; PATIENT COMPLIANCE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS;

EID: 77955490414     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21749     Document Type: Article

References (30)

1. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia.Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-1322.
2. Shapiro BS, Dinges DF, Orne EC, et al. Home management of sickle cell-related pain in children and adolescents: Natural history and impact on school attendance. Pain 1995;61:139-144.
3. Dampier C, Ely E, Brodecki D, et al. Home management of pain in sickle cell disease: A daily diary study in children and adolescents. J Pediatr Hematol Oncol 2002;24:643-647.
4. Wang WC, Wang WC. Pain at home in sickle cell disease: An underrecognized problem. J Pediatr Hematol Oncol 2002;24:610-612.
5. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-1651.
6. Scott JP, Hillery CA, Brown ER, et al. Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 1996;128:820-828.
7. Jayabose S, Tugal O, Sandoval C, et al. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 1996;129:559-565.
8. Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial. Blood 1996;88:1960-1964.
9. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004;103:2039-2045.
10. Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood 2005; 106:2269-2275.
11. Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial.Pediatric Hydroxyurea Group. Blood 1999;94:1550-1554.
12. Heeney MM, Ware RE. Hydroxyurea for children with sickle cell disease. Pediatr Clin North Am 2008;55:483-501.
13. Zumberg MS, Reddy S, Boyette RL, et al. Hydroxyurea therapy for sickle cell disease in community-based practices: A survey of Florida and North Carolina hematologists/oncologists. Am J Hematol 2005;79:107-113.
14. Lanzkron S, Haywood C, Jr., Hassell KL, et al. Provider barriers to hydroxyurea use in adults with sickle cell disease: A survey of the Sickle Cell Disease Adult Provider Network. J Natl Med Assoc 2008;100:968-973.
15. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008;148:932-938.
16. NIH. The Management of Sickle Cell Disease. NIH; Bethesda, MD, 2002. pp 161-165.
17. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008;148:94-101.
18. Debaun MR, Field JJ. Limitations of clinical trials in sickle cell disease: A case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. Hematology Am Soc Hematol Educ Program 2007:482-488.
19. Brandow AM, Brousseau DC, Pajewski NM, et al. Vaso-occlusive painful events in sickle cell disease: Impact on child well-being. Pediatr Blood Cancer 2010;54:92-97.
20. Brandow AM, Brousseau DC, Panepinto JA, et al. Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. Br J Haematol 2009;144:782-788.
21. Thornburg CD, Calatroni A, Telen M, et al. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr 2010;156:415-419.
22. Segal JB, Strouse JJ, Beach MC, et al. Hydroxyurea for the treatment of sickle cell disease. Evid Rep Technol Assess (Full Rep)2008:1-95.
23. Ballas SK, McCarthy WF, Guo N, et al.; Multicenter Study of Hydroxyurea in Sickle Cell A. Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia. J Natl Med Assoc 2009;101:1046-1051.
24. National Heart, Lung, and Blood Institute (NHLBI). Hydroxyurea to prevent organ damage in children with sickle cell anemia. In: Clinical Trialsgov [Internet]. Bethesda (MD):National Library of Medicine (US). Available at: http://clinicaltrials.gov/show/NCT00006400, NLM Identifier: NCT00006400. Accessed 9 February 2010.
25. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001;97: 3628-3632.
26. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001;139: 790-796.
27. Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: A survey of American Society of Hematology members' practice patterns. Blood 2002; 99:1144-1149.
28. Lee SJ, Joffe S, Kim HT, et al. Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. Blood 2004;104:2194-2200.
29. Wong EC, Perez-Albuerne E, Moscow JA, et al. Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists. Pediatr Blood Cancer 2005;44:119-127.
30. Goodman, G. Constant Contact, Waltham, MA. Available at: wwwconstantcontactcom. Accessed 1 February 2009.